VTCN1 and neoplasm: B7-H4 tumor protein expression in the tumor cell component was high in 257/561 (45.8%) of the Yale cohort patients and 198/444 (44.6%) of the UM cohort patients (Table 1; Supplementary Fig. 1a, b).